NIH-funded research R01 grant

Using MRI to understand and prevent atypical femoral fractures

Official title: Leveraging MRI Technology for Atypical Femoral Fracture Risk Management

Funded at University of Pennsylvania · NIH-11295059 · Data updated 2026-11-12

A health study to find MRI-based signs that predict atypical femoral fractures so doctors can tailor osteoporosis treatment and reduce dangerous breaks.

More Fracture research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 1, 2026
Project endJuly 31, 2031
Funding year2026
Award (this year)$625,568
NIH project number1R01AR085593-01A1
Project IDNIH-11295059 on NIH RePORTER

Who could benefit from this research

Could help

Adults at risk for osteoporosis who may be considered for long-term antiresorptive therapy and who have concerns about AFF risk.

Less likely to help

Patients with low AFF risk or those not undergoing antiresorptive therapy may see little direct benefit.

What this research studies

This project will look at MRI images to identify measurable bone features that indicate higher risk of atypical femoral fractures (AFF). Researchers will create a tiered screening approach to help decide how long osteoporosis drugs should be used and when to pause treatment. The goal is to help patients by reducing fracture risk while avoiding unnecessary drug exposure, using imaging data and clinical factors. The study is based at the University of Pennsylvania with a focus on translating imaging findings into practical risk tools for clinicians and patients.

Why it matters

Potential benefit: If successful, patients at higher AFF risk could receive more personalized osteoporosis treatment plans to prevent fractures.

How similar studies have gone: Prior work links imaging phenotypes to fracture risk, but this aims to create a systematic, patient-specific AFF risk screen.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Rajapakse, Chamith Sudesh — University of Pennsylvania
  • Study coordinator: Rajapakse, Chamith Sudesh

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.